Net shares · 365d
+1.0K
1.0K buy · 0 sell
Net value · 365d
$647.4K
$647.4K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
1
1.0K buy · 0 sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
LLY Grant·A
EVP,Pres LLY Oncology&HdCorpBD
$5.1M
4.9K sh · $1,044.67
Own +22%
-
LLY Exercise·M
EVP,Pres LLY Oncology&HdCorpBD
$0
4.1K sh
Own New
-
LLY Exercise·M
EVP,Pres LLY Oncology&HdCorpBD
$0
4.1K sh
Own +20%
-
LLY Other·F
EVP,Pres LLY Oncology&HdCorpBD
$2.0M
1.9K sh · $1,037.15
Own -8%
-
LLY Buy·P
EVP & Pres., Lilly Oncology
$647.4K
1.0K sh · $647.36
Own +5%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Feb 9, 2026 | LLY | Grant A | 4.9K | $5.1M |
| Feb 1, 2026 | LLY | Exercise M | 4.1K | $0 |
| Feb 1, 2026 | LLY | Exercise M | 4.1K | $0 |
| Feb 1, 2026 | LLY | Other F | 1.9K | $2.0M |
| Aug 13, 2025 | LLY | Buy P | 1.0K | $647.4K |
Buy Sell Non-market (grant · exercise · gift)
About Van Naarden Jacob
This profile aggregates every SEC Form 4 insider transaction reported by Van Naarden Jacob across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.